secwatch.observer — SEC 8-K summary
======================================

Issuer:     Semnur Pharmaceuticals, Inc. (SMNR)
CIK:        0001913577
Form:       8-K
Filed at:   2026-06-25T21:03:49+00:00
Accession:  0001193125-26-283007
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Semnur stockholders elect director, ratify auditor, approve 2025 equity plans at annual meeting
--------------------------------------------------------------------------------

- Jay Chun, M.D., Ph.D. elected Class I director with 200,166,258 for, 3,804 withheld, 137,409 broker non-votes.
- Ratification of Pipara & Co LLP as auditor for FY 2026: 200,307,425 for, 46 against, 0 abstentions.
- 2025 Equity Incentive Plan approved: 200,166,256 for, 269 against, 3,537 abstentions, 137,409 broker non-votes.
- 2025 Employee Stock Purchase Plan approved: 200,166,255 for, 270 against, 3,537 abstentions, 137,409 broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1913577/000119312526283007/0001193125-26-283007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1913577/000119312526283007/smnr-20260625.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-283007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer